NCT04479124

Brief Summary

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. The aim of this multi-centered study is to guide for the approach, organization, diagnosis and treatment of the patients admitted due to trauma to emergency department during the pandemic period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2020

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

July 19, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 21, 2020

Completed
Last Updated

July 21, 2020

Status Verified

July 1, 2020

Enrollment Period

4 months

First QC Date

July 19, 2020

Last Update Submit

July 19, 2020

Conditions

TraumaCovid19

Outcome Measures

Primary Outcomes (1)

  • trauma admissions

    within the study period, trauma patients who admitted to any of the seven study centers will be recorded.

    3 months

Interventions

COVID-19 PCRDIAGNOSTIC_TEST

Nasopharyngeal samples were analyzed by PCR for the detection of Novel Coronavirus 2019 DNA

Eligibility Criteria

AgeUp to 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The patients who admitted to any of the emergency departments of seven study centers during the pandemic will be evaluated.

You may qualify if:

  • accepted to participate with an informed consent
  • trauma patients who admitted to the study centers

You may not qualify if:

  • lack of informed consent
  • lack of data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, Kucukcekmece, 34303, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Wounds and InjuriesCOVID-19

Interventions

COVID-19 Nucleic Acid Testing

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

COVID-19 TestingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Proffessor

Study Record Dates

First Submitted

July 19, 2020

First Posted

July 21, 2020

Study Start

March 10, 2020

Primary Completion

June 30, 2020

Study Completion

July 14, 2020

Last Updated

July 21, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)